ACADIA Pharmaceuticals Appoints Julian C. Baker to Board of Directors

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced Julian C. Baker has joined its Board of Directors. “After more than 20 years as a professional investor, Julian has extensive experience in financing and building companies in the life sciences industry,” said Leslie L. Iversen, Ph.D., Chairm